XML 20 R2.htm IDEA: XBRL DOCUMENT v3.24.3
CONSOLIDATED BALANCE SHEETS - USD ($)
Aug. 31, 2024
Aug. 31, 2023
Current    
Cash $ 6,499,885 $ 1,352,102
Marketable securities 55,807 125,642
Accounts receivable 154,477 126,686
Prepaid expenses and other current assets 1,187,817 546,783
Total Current Assets 7,897,986 2,151,213
Non-current assets, net    
Long-term receivables 63,575 48,559
Right of use assets 134,843 167,446
Property & equipment, net 254,709 254,143
Intellectual property, net 516,676 462,625
Total Non-current assets 969,803 932,773
TOTAL ASSETS 8,867,789 3,083,986
Current Liabilities    
Accounts payable and accrued liabilities 1,066,409 239,941
Deferred revenue 4,963 0
Lease liability, current 28,047 27,794
Total Current Liabilities 1,099,419 267,735
Lease liability, non-current 109,319 136,173
TOTAL LIABILITIES 1,208,738 403,908
Stockholders' Equity    
Share Capital Authorized: 220,000,000 common voting shares with a par value of $0.001 per share Common shares issued and outstanding: 15,810,205 and 8,091,650 at August 31, 2024, and August 31, 2023, respectively 15,810 8,091
Additional paid-in capital 59,599,178 48,799,454
Accumulated Deficit (51,558,772) (45,763,427)
Accumulated other comprehensive loss (19,816) 0
Equity attributable to shareholders of Lexaria 8,036,400 3,044,118
Non-controlling Interest (377,349) (364,040)
Total Stockholders' Equity 7,659,051 2,680,078
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 8,867,789 $ 3,083,986